Australian University Rankings Guide

Advances in Protein Chemistry (ERA Journal)

Advances in Protein Chemistry is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Advances in Protein Chemistry issns are issn1: 0065-3233 issn2: 1557-8941.

The fields covered by Advances in Protein Chemistry as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Biochemistry and Cell Biology Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- Anti-Cancer Agents in Medicinal Chemistry
- Anti-Cancer Drugs: international journal on anti-cancer agents
- Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
- BioMolecular Concepts
- Chemical Research in Toxicology
- Current Cancer Drug Targets
- European Journal of Medicinal Chemistry
- Experimental and Molecular Medicine
- International Journal of Bioscience Biochemistry and Bioinformatics (IJBBB)
- Journal of Biophotonics
- Journal of Chemical Information and Modeling
- Molecular Genetics and Genomic Medicine
- Pharmacology Research and Perspectives
- The Federation of European Biochemical Societies (FEBS) Journal
- eJIFCC - electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4